Bioclinix Formulations Private Limited - Company Profile

It is a food and beverages private limited company based in Rangareddy, Telangana, India, established in 2017.
2017 Rangareddy, Telangana, India Struck Off
Last Updated:
Access Report
About Bioclinix Formulations Private Limited

Bioclinix Formulations Private Limited, a struck off private limited company, was established on 25 October 2017 in Rangareddy, Telangana, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24303TG2017PTC120251. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Gurram Bharath Chandra (Director), Karthik Bolgam (Director), Sri Krishna Chaitanya Boyapati (Director). It is based at H.No.2-89/1/5/9/A, 2Nd Floor, Gopanpally Village,Gachibowli, Rangareddy, Telangana, 500046.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24303TG2017PTC120251

  • Registration Number

    120251

  • Incorporation Date

    25 October 2017

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 4 Months
Company report

Bioclinix Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bioclinix Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bioclinix Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Gurram Bharath Chandra Director 25 Oct 2017 Current
Karthik Bolgam Director 25 Oct 2017 Current
Sri Krishna Chaitanya Boyapati Director 25 Oct 2017 Current
Kiran Kumar Kantayapalem Director 25 Oct 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bioclinix Formulations.

Enhance accessibility to Bioclinix Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Bioclinix Formulations revenue growth over time
Bioclinix Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bioclinix Formulations?

Unlock access to Bioclinix Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bioclinix Formulations?

Unlock and access historical data on people associated with Bioclinix Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bioclinix Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioclinix Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bioclinix Formulations
Recent Activity within the Organization
  • Director Appointment

    Progress on Gurram Bharath Chandra was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 4 months . was documented.

  • Director Appointment

    Progress on Karthik Bolgam was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 4 months . was documented.

  • Director Appointment

    The activity Sri Krishna Chaitanya Boyapati was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 4 months . was completed.

  • Director Appointment

    The activity Kiran Kumar Kantayapalem was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 4 months . was completed.

  • Company Incorporation

    The activity Bioclinix Formulations Private Limited was registered on 25 Oct 2017 with Roc Hyderabad & aged 8 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bioclinix Formulations Private Limited?

The CIN of Bioclinix Formulations Private Limited is U24303TG2017PTC120251.

Where is Bioclinix Formulations Private Limited headquartered?

Bioclinix Formulations Private Limited is headquartered at H.No.2-89/1/5/9/A, 2Nd Floor, Gopanpally Village,Gachibowli, Rangareddy, Telangana, 500046.

When was Bioclinix Formulations Private Limited incorporated?

Bioclinix Formulations Private Limited was incorporated on 25 October 2017.

Who are the current directors of Bioclinix Formulations Private Limited?

The current directors of Bioclinix Formulations Private Limited are

What is the primary industry of Bioclinix Formulations Private Limited?

The primary industry of Bioclinix Formulations Private Limited is Food And Beverages.

Is Bioclinix Formulations Private Limited a listed company?

Bioclinix Formulations Private Limited is unlisted.

What is the capital structure of Bioclinix Formulations Private Limited?

The authorized capital of Bioclinix Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Bioclinix Formulations Private Limited?

The compliance status of Bioclinix Formulations Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available